Company / Working Capital per Share
Gossamer Bio, Inc. Working Capital per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.46
FY2025
5-year range
$0.46 / $3.90
FY2021-FY2025
Trend
-60.9%
vs FY2024
Sector context
#196 of 210
Health Care
What the data says
Among 210 Health Care companies, Gossamer Bio, Inc. is in the bottom 7% for working capital per share. Working Capital per Share has declined for 5 consecutive years, from $7.06 in FY2020 to $0.46 in FY2025.
Based on SEC 10-K filings.
0.46 in FY2025 with a 5-year CAGR of -42.1%.
Declined from $1.67 to $0.46 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -43.2%
- 5-Year CAGR
- -42.1%
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 210This company $0.46 Sector average $146.86
▼
-99.7% below sector average
Key checks
Key Insights
- Gossamer Bio, Inc.'s working capital per share has declined for 5 consecutive years.
- In FY2025, working capital per share decreased 60.9% year-over-year.
- Ranks #196 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -9.62 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.46 | -60.9% |
| FY2024 | $1.18 | -29.6% |
| FY2023 | $1.67 | -33.6% |
| FY2022 | $2.51 | -35.5% |
| FY2021 | $3.90 | -44.8% |
| FY2020 | $7.06 | +3.8% |
| FY2019 | $6.80 | -79.1% |
| FY2018 | $32.52 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026